Corrections belong to the record

The editorial mailbox brief

Correspondence for Clover Peptides Review concerns the literature and its interpretation. Useful subjects include a citation attached to the wrong claim, a species left unstated, a formulation confused with another material, or an endpoint described more broadly than the paper supports.

The repair theme also gives correspondence a specific focus: a skin finding described as whole-body repair, surrounding tissue assumed to have healed, or a distant organ assigned a benefit that was never measured. These are matters of editorial accuracy, even when the broader biological story sounds plausible. A correction brief should identify the page, section and disputed sentence so the claim can be located precisely.

What makes a source correction assessable

A useful note identifies the cited paper by its numbered entry in the source register, states the proposed correction and explains the discrepancy. The distinction between tested material and marketed name is especially relevant to the TB-500 entry; the distinction between a combination and a single compound is relevant elsewhere.

A proposed wording change is most useful when it retains the original model and endpoint while making the evidence boundary more explicit.

Additional published findings can be identified by title, authors and journal, with a stable source link where available. A proposed addition should distinguish an original experiment, review, trial record or community report. Unpublished assertions and product testimonials cannot replace study evidence. Editorial correspondence should keep private health information out of the source discussion.

Scope of correspondence and availability

This edition lists no public mailbox address or submission form. The page defines the editorial correspondence brief without inventing an operational contact route. It is not a patient intake, booking service or product inquiry channel.

Personal dosing questions, supplier requests, individual recovery forecasts and treatment decisions are outside the publication's scope. The digest interprets a defined research record; it does not assess a person's condition or authenticate commercial preparations. Regulatory and anti-doping changes also require an identifiable source rather than a casual status claim.

The editorial method explains how findings are weighted. The source register identifies the papers currently cited, and the comparison shows how tissue location constrains interpretation. These pages supply the context for a specific correction rather than a general request for a peptide recommendation.